1 position(s) for US and Worldwide Medical Strategy: Immunology
Fellowship Position Office Location: Lawrenceville, NJ 08648
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships and Bristol Myers Squibb Program emphasis is in US and Worldwide Medical Strategy: Immunology
This two-year fellowship provides a unique opportunity to work in two of the most exciting and competitive areas of immunology research and pharmaceutical development today: Dermatology and Rheumatology. Individuals participating in this fellowship will gain a broad understanding of Medical Affairs through both participatory and leadership experiences from the perspective of both the US and Worldwide Medical Strategy Teams. During the fellowship, the Fellow is expected to experience several important market events including post-launch support in dermatology and several phase 2/phase 3 study read outs. Graduates of this fellowship have gone on to lead successful careers in various aspects of Medical Affairs including Medical Strategy, Scientific Communications, Clinical Development, Medical Science Liaison, Medical
Information, and Independent Medical Education.
US MEDICAL STRATEGY – DERMATOLOGY
Participate in strategic planning with the US Medical Matrix Team based on unmet medical needs from the perspectives of patients, providers, and payers.
Lead medical projects in partnership with the broader medical matrix team members (Field Medical, Medical Information, Independent Medical Education, Sales, Marketing, Outcomes Research, Promotional Integrity, Legal, and Global Pharmacovigilance & Epidemiology)
Lead and participate in key aspects of medical affairs including data generation, content development, training, insight reporting, advisory boards, and congress planning.
Conduct medical review of promotional and non-promotional materials in collaboration with Legal, Regulatory, and Marketing teams.
WORLDWIDE MEDICAL STRATEGY – DERMATOLOGY & RHEUMATOLOGY
Lead development and execution of the Global Medical Plan in partnership with key international market teams (eg, US, EU, Asia-Pacific), Clinical Development, & Commercial
Prepare for a commercial launch and several Phase 2/3 data releases for deucravacitinib (a selective TYK2 inhibitor) in Rheumatology.
Engage International Key Opinion Leaders via advisory boards, steering committees, MSLs, and international conferences to inform and elevate BMS strategy.
Identify educational needs among Rheumatologists and Dermatologists and execute plans to fulfill them, eg, disease education, pathway materials, conference symposia, review articles.
Develop integrated data generation plans and review/approve investigator sponsored research proposals to inform appropriate use of BMS medicines and fulfill unmet medical needs.
University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the Apply Now button to the right. We do not pre-schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
The RPIF program will be conducting initial interviews on a rolling basis virtually (video/teleconference) starting October 23rd. To apply, candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu/how-to-apply/) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below.Remember that the application process is on a rolling basis, so earlier is better. Please see our website for additional important recruitment information and dates.
Once all interviews have been completed, Rutgers or the company will notify interviewed candidates of their position-specific candidacy status.
Create an RPIF Candidate Account starting now.
Upload RPIF Application Materials to RPIF Candidate Account starting October 06, 2023.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and upload your Letter of Intent and Curriculum Vitae (CV) by October 13, 2023.
Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2023.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.
Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.